questionsmedicales.fr
Eucaryotes
Viridiplantae
Streptophyta
Embryophyta
Tracheobionta
Magnoliopsida
Boraginaceae
Boraginaceae : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Plantes médicinales
Botanique
Essais cliniques
Phytothérapie
Identification botanique
Phytothérapie
Classification des plantes
Botanique
Outils de diagnostic
Botanique
Symptômes
5
Réactions allergiques
Effets secondaires
Effets indésirables
Phytothérapie
Allergies
Réactions cutanées
Troubles respiratoires
Allergies
Prévention
5
Prévention
Effets indésirables
Précautions
Consultation médicale
Interactions médicamenteuses
Phytothérapie
Stockage
Préparations médicinales
Recommandations
Phytothérapie
Traitements
5
Médecine traditionnelle
Phytothérapie
Remèdes naturels
Phytothérapie
Inflammation
Efficacité thérapeutique
Préparation de remèdes
Phytothérapie
Contre-indications
Phytothérapie
Complications
5
Réaction allergique
Consultation médicale
Maladies préexistantes
Complications
Facteurs de risque
5
Allergies
Facteurs de risque
Intoxication
Facteurs de risque
Personnes âgées
Vulnérabilité
Maladies chroniques
Précautions
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Boraginaceae : Questions médicales les plus fréquentes",
"headline": "Boraginaceae : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Boraginaceae : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-13",
"dateModified": "2025-04-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Boraginaceae"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Magnoliopsida",
"url": "https://questionsmedicales.fr/mesh/D019684",
"about": {
"@type": "MedicalCondition",
"name": "Magnoliopsida",
"code": {
"@type": "MedicalCode",
"code": "D019684",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Amsinckia",
"alternateName": "Amsinckia",
"url": "https://questionsmedicales.fr/mesh/D029682",
"about": {
"@type": "MedicalCondition",
"name": "Amsinckia",
"code": {
"@type": "MedicalCode",
"code": "D029682",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.122"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Borago",
"alternateName": "Borago",
"url": "https://questionsmedicales.fr/mesh/D029683",
"about": {
"@type": "MedicalCondition",
"name": "Borago",
"code": {
"@type": "MedicalCode",
"code": "D029683",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.188"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Consoude",
"alternateName": "Comfrey",
"url": "https://questionsmedicales.fr/mesh/D020844",
"about": {
"@type": "MedicalCondition",
"name": "Consoude",
"code": {
"@type": "MedicalCode",
"code": "D020844",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.210"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cordia",
"alternateName": "Cordia",
"url": "https://questionsmedicales.fr/mesh/D031213",
"about": {
"@type": "MedicalCondition",
"name": "Cordia",
"code": {
"@type": "MedicalCode",
"code": "D031213",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.327"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Echium",
"alternateName": "Echium",
"url": "https://questionsmedicales.fr/mesh/D036661",
"about": {
"@type": "MedicalCondition",
"name": "Echium",
"code": {
"@type": "MedicalCode",
"code": "D036661",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.385"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Eriodictyon",
"alternateName": "Eriodictyon",
"url": "https://questionsmedicales.fr/mesh/D031322",
"about": {
"@type": "MedicalCondition",
"name": "Eriodictyon",
"code": {
"@type": "MedicalCode",
"code": "D031322",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.415"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Heliotropium",
"alternateName": "Heliotropium",
"url": "https://questionsmedicales.fr/mesh/D028162",
"about": {
"@type": "MedicalCondition",
"name": "Heliotropium",
"code": {
"@type": "MedicalCode",
"code": "D028162",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.444"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lithospermum",
"alternateName": "Lithospermum",
"url": "https://questionsmedicales.fr/mesh/D029684",
"about": {
"@type": "MedicalCondition",
"name": "Lithospermum",
"code": {
"@type": "MedicalCode",
"code": "D029684",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.501"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pulmonaria",
"alternateName": "Pulmonaria",
"url": "https://questionsmedicales.fr/mesh/D029685",
"about": {
"@type": "MedicalCondition",
"name": "Pulmonaria",
"code": {
"@type": "MedicalCode",
"code": "D029685",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Boraginaceae",
"alternateName": "Boraginaceae",
"code": {
"@type": "MedicalCode",
"code": "D028082",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Maryam Noroozi",
"url": "https://questionsmedicales.fr/author/Maryam%20Noroozi",
"affiliation": {
"@type": "Organization",
"name": "Department of Ecology & Evolutionary Biology, University of Tennessee, Knoxville, TN, 37996, USA."
}
},
{
"@type": "Person",
"name": "Farrokh Ghahremaninejad",
"url": "https://questionsmedicales.fr/author/Farrokh%20Ghahremaninejad",
"affiliation": {
"@type": "Organization",
"name": "Department of Plant Sciences, Faculty of Biological Sciences, Kharazmi University, Tehran, 15719-14911, Iran. fgh@khu.ac.ir."
}
},
{
"@type": "Person",
"name": "Mehrshid Riahi",
"url": "https://questionsmedicales.fr/author/Mehrshid%20Riahi",
"affiliation": {
"@type": "Organization",
"name": "Department of Plant Sciences, Faculty of Biological Sciences, Kharazmi University, Tehran, 15719-14911, Iran."
}
},
{
"@type": "Person",
"name": "James I Cohen",
"url": "https://questionsmedicales.fr/author/James%20I%20Cohen",
"affiliation": {
"@type": "Organization",
"name": "Department of Botany and Plant Ecology, Weber State University, 1415 Edvalson St., Dept. 2504, Ogden, UT, 84408, USA."
}
},
{
"@type": "Person",
"name": "José Luis Guil-Guerrero",
"url": "https://questionsmedicales.fr/author/Jos%C3%A9%20Luis%20Guil-Guerrero",
"affiliation": {
"@type": "Organization",
"name": "Food Technology Division, University of Almería, 04120, Almería, Spain."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The safety of the combination therapy of recombinant factor VIIa and plasma-derived factor VIIa and factor X for refractory hemorrhage in acquired hemophilia A.",
"datePublished": "2023-07-19",
"url": "https://questionsmedicales.fr/article/37577920",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MBC.0000000000001243"
}
},
{
"@type": "ScholarlyArticle",
"name": "Plasma-derived factor VIIa and factor X mixture agent (MC710) prophylaxis in haemophilia B patients with inhibitors.",
"datePublished": "2022-12-14",
"url": "https://questionsmedicales.fr/article/36516312",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/hae.14710"
}
},
{
"@type": "ScholarlyArticle",
"name": "Activated factor XI is associated with increased factor VIIa - Antithrombin complexes in stable coronary artery disease: Impact on cardiovascular outcomes.",
"datePublished": "2022-08-29",
"url": "https://questionsmedicales.fr/article/35996895",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/eci.13857"
}
},
{
"@type": "ScholarlyArticle",
"name": "Exploring Hematoma Expansion Shift With Recombinant Factor VIIa: A Pooled Analysis of 4 Randomized Controlled Trials.",
"datePublished": "2023-10-08",
"url": "https://questionsmedicales.fr/article/37805927",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1161/STROKEAHA.123.043209"
}
},
{
"@type": "ScholarlyArticle",
"name": "Local pulmonary administration of factor VIIa (rFVIIa) in massive pulmonary haemorrhage in post-operative cardiac infant.",
"datePublished": "2022-09-26",
"url": "https://questionsmedicales.fr/article/36156187",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1017/S1047951122003006"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Eucaryotes",
"item": "https://questionsmedicales.fr/mesh/D056890"
},
{
"@type": "ListItem",
"position": 3,
"name": "Viridiplantae",
"item": "https://questionsmedicales.fr/mesh/D057948"
},
{
"@type": "ListItem",
"position": 4,
"name": "Streptophyta",
"item": "https://questionsmedicales.fr/mesh/D057949"
},
{
"@type": "ListItem",
"position": 5,
"name": "Embryophyta",
"item": "https://questionsmedicales.fr/mesh/D019669"
},
{
"@type": "ListItem",
"position": 6,
"name": "Tracheobionta",
"item": "https://questionsmedicales.fr/mesh/D064028"
},
{
"@type": "ListItem",
"position": 7,
"name": "Magnoliopsida",
"item": "https://questionsmedicales.fr/mesh/D019684"
},
{
"@type": "ListItem",
"position": 8,
"name": "Boraginaceae",
"item": "https://questionsmedicales.fr/mesh/D028082"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Boraginaceae - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Boraginaceae",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Boraginaceae",
"description": "Comment identifier les plantes de la famille Boraginaceae ?\nQuels tests pour évaluer l'efficacité des Boraginaceae ?\nY a-t-il des critères spécifiques pour le diagnostic ?\nComment distinguer les Boraginaceae des autres familles ?\nQuels outils pour identifier les Boraginaceae ?",
"url": "https://questionsmedicales.fr/mesh/D028082?mesh_terms=Factor+VIIa#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Boraginaceae",
"description": "Quels symptômes sont associés à l'utilisation des Boraginaceae ?\nLes Boraginaceae provoquent-elles des effets indésirables ?\nQuels symptômes d'intoxication peuvent survenir ?\nComment reconnaître une réaction allergique aux Boraginaceae ?\nLes Boraginaceae peuvent-elles causer des troubles respiratoires ?",
"url": "https://questionsmedicales.fr/mesh/D028082?mesh_terms=Factor+VIIa#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Boraginaceae",
"description": "Comment éviter les effets indésirables des Boraginaceae ?\nQuelles précautions prendre avant d'utiliser des Boraginaceae ?\nLes Boraginaceae peuvent-elles interagir avec d'autres médicaments ?\nComment stocker les préparations à base de Boraginaceae ?\nY a-t-il des recommandations pour l'utilisation des Boraginaceae ?",
"url": "https://questionsmedicales.fr/mesh/D028082?mesh_terms=Factor+VIIa#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Boraginaceae",
"description": "Comment les Boraginaceae sont-elles utilisées en médecine ?\nQuels remèdes à base de Boraginaceae existent ?\nLes Boraginaceae sont-elles efficaces contre l'inflammation ?\nComment préparer un remède à base de Boraginaceae ?\nY a-t-il des contre-indications pour les traitements à base de Boraginaceae ?",
"url": "https://questionsmedicales.fr/mesh/D028082?mesh_terms=Factor+VIIa#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Boraginaceae",
"description": "Quelles complications peuvent survenir avec les Boraginaceae ?\nLes Boraginaceae peuvent-elles causer des problèmes hépatiques ?\nComment gérer une réaction allergique aux Boraginaceae ?\nY a-t-il des risques d'intoxication avec les Boraginaceae ?\nLes Boraginaceae peuvent-elles aggraver des maladies existantes ?",
"url": "https://questionsmedicales.fr/mesh/D028082?mesh_terms=Factor+VIIa#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Boraginaceae",
"description": "Qui est à risque d'allergies aux Boraginaceae ?\nLes femmes enceintes doivent-elles éviter les Boraginaceae ?\nQuels facteurs augmentent le risque d'intoxication ?\nLes personnes âgées sont-elles plus vulnérables ?\nY a-t-il des risques pour les personnes atteintes de maladies chroniques ?",
"url": "https://questionsmedicales.fr/mesh/D028082?mesh_terms=Factor+VIIa#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier les plantes de la famille Boraginaceae ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les Boraginaceae se caractérisent par des fleurs en grappes et des feuilles alternées."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer l'efficacité des Boraginaceae ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études cliniques et des tests in vitro sont utilisés pour évaluer leur efficacité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des critères spécifiques pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'identification botanique et l'analyse des propriétés médicinales."
}
},
{
"@type": "Question",
"name": "Comment distinguer les Boraginaceae des autres familles ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'observation des caractéristiques florales et des feuilles aide à la distinction."
}
},
{
"@type": "Question",
"name": "Quels outils pour identifier les Boraginaceae ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des guides botaniques et des applications de reconnaissance de plantes sont utiles."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à l'utilisation des Boraginaceae ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réactions allergiques, des troubles gastro-intestinaux ou des effets secondaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les Boraginaceae provoquent-elles des effets indésirables ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines espèces peuvent causer des effets indésirables comme des nausées."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'intoxication peuvent survenir ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes tels que des vomissements, des douleurs abdominales peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique aux Boraginaceae ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des démangeaisons, éruptions cutanées ou œdème peuvent indiquer une allergie."
}
},
{
"@type": "Question",
"name": "Les Boraginaceae peuvent-elles causer des troubles respiratoires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles respiratoires peuvent survenir en cas d'allergie ou d'intoxication."
}
},
{
"@type": "Question",
"name": "Comment éviter les effets indésirables des Boraginaceae ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de commencer par de faibles doses et de surveiller les réactions."
}
},
{
"@type": "Question",
"name": "Quelles précautions prendre avant d'utiliser des Boraginaceae ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consulter un professionnel de santé avant utilisation, surtout en cas de maladies préexistantes."
}
},
{
"@type": "Question",
"name": "Les Boraginaceae peuvent-elles interagir avec d'autres médicaments ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent interagir avec certains médicaments, il est donc important de vérifier."
}
},
{
"@type": "Question",
"name": "Comment stocker les préparations à base de Boraginaceae ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Conserver dans un endroit frais et sec, à l'abri de la lumière pour préserver l'efficacité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations pour l'utilisation des Boraginaceae ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Suivre les recommandations d'un professionnel de santé et respecter les dosages conseillés."
}
},
{
"@type": "Question",
"name": "Comment les Boraginaceae sont-elles utilisées en médecine ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont utilisées pour traiter des inflammations, des douleurs et des troubles cutanés."
}
},
{
"@type": "Question",
"name": "Quels remèdes à base de Boraginaceae existent ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infusions, des pommades et des extraits sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les Boraginaceae sont-elles efficaces contre l'inflammation ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études montrent qu'elles peuvent réduire l'inflammation et la douleur."
}
},
{
"@type": "Question",
"name": "Comment préparer un remède à base de Boraginaceae ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les feuilles peuvent être infusées ou utilisées en cataplasme pour des applications topiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des contre-indications pour les traitements à base de Boraginaceae ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes, comme les femmes enceintes, doivent éviter leur utilisation."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les Boraginaceae ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des allergies sévères ou des troubles gastro-intestinaux peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les Boraginaceae peuvent-elles causer des problèmes hépatiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines espèces contiennent des composés toxiques pouvant affecter le foie."
}
},
{
"@type": "Question",
"name": "Comment gérer une réaction allergique aux Boraginaceae ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cesser l'utilisation immédiatement et consulter un médecin si les symptômes persistent."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques d'intoxication avec les Boraginaceae ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une consommation excessive peut entraîner des symptômes d'intoxication."
}
},
{
"@type": "Question",
"name": "Les Boraginaceae peuvent-elles aggraver des maladies existantes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent aggraver certaines conditions, comme les maladies hépatiques ou rénales."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'allergies aux Boraginaceae ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes ayant des antécédents d'allergies aux plantes sont plus à risque."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles éviter les Boraginaceae ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est recommandé qu'elles évitent leur utilisation en raison de risques potentiels."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'intoxication ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une consommation excessive ou l'utilisation de préparations non contrôlées augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus vulnérables ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être plus sensibles aux effets indésirables des Boraginaceae."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques pour les personnes atteintes de maladies chroniques ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes atteintes de maladies chroniques doivent être prudentes avec leur utilisation."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 08/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Ecology & Evolutionary Biology, University of Tennessee, Knoxville, TN, 37996, USA.
Department of Plant Sciences, Faculty of Biological Sciences, Kharazmi University, Tehran, 15719-14911, Iran.
Publications dans "Boraginaceae" :
2 publications dans cette catégorie
Affiliations :
Department of Plant Sciences, Faculty of Biological Sciences, Kharazmi University, Tehran, 15719-14911, Iran. fgh@khu.ac.ir.
Publications dans "Boraginaceae" :
2 publications dans cette catégorie
Affiliations :
Department of Plant Sciences, Faculty of Biological Sciences, Kharazmi University, Tehran, 15719-14911, Iran.
Publications dans "Boraginaceae" :
2 publications dans cette catégorie
Affiliations :
Department of Botany and Plant Ecology, Weber State University, 1415 Edvalson St., Dept. 2504, Ogden, UT, 84408, USA.
Publications dans "Boraginaceae" :
2 publications dans cette catégorie
Affiliations :
Food Technology Division, University of Almería, 04120, Almería, Spain.
Publications dans "Boraginaceae" :
2 publications dans cette catégorie
Affiliations :
Food Technology Division, University of Almería, 04120, Almería, Spain.
Publications dans "Boraginaceae" :
2 publications dans cette catégorie
Affiliations :
Food Technology Division, University of Almería, 04120, Almería, Spain.
Publications dans "Boraginaceae" :
2 publications dans cette catégorie
Affiliations :
Institute of Biology, Faculty of Natural Sciences and Mathematics, Ss. Cyril and Methodius University, Skopje, R. N. Macedonia.
Macedonian Academy of Sciences and Arts, Krste Misirkov 2, 1000, Skopje, R. N. Macedonia.
Publications dans "Boraginaceae" :
2 publications dans cette catégorie
Affiliations :
Institute of Chemistry, Faculty of Natural Sciences and Mathematics, Ss. Cyril and Methodius University, Skopje, R. N. Macedonia.
Publications dans "Boraginaceae" :
2 publications dans cette catégorie
Affiliations :
Kutateladze Institute of Pharmacochemistry, Tbilisi State Medical University, 36 P.Sarajishvili Street, 0159 Tbilisi, Georgia.
Publications dans "Boraginaceae" :
2 publications dans cette catégorie
Affiliations :
Kutateladze Institute of Pharmacochemistry, Tbilisi State Medical University, 36 P.Sarajishvili Street, 0159 Tbilisi, Georgia.
Publications dans "Boraginaceae" :
2 publications dans cette catégorie
Affiliations :
Kutateladze Institute of Pharmacochemistry, Tbilisi State Medical University, 36 P.Sarajishvili Street, 0159 Tbilisi, Georgia.
Publications dans "Boraginaceae" :
2 publications dans cette catégorie
Affiliations :
Kutateladze Institute of Pharmacochemistry, Tbilisi State Medical University, 36 P.Sarajishvili Street, 0159 Tbilisi, Georgia.
Publications dans "Boraginaceae" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Aristotle University, 54124 Thessaloniki, Greece.
Publications dans "Boraginaceae" :
1 publication dans cette catégorie
Affiliations :
Grainger Bioinformatics Center, Department of Science and Education, The Field Museum, Chicago, Illinois, USA.
Departamento de Biodiversidad y Conservación, Real Jardín Botánico (RJB-CSIC), Madrid, Spain.
Publications dans "Boraginaceae" :
1 publication dans cette catégorie
Affiliations :
Departamento de Biodiversidad y Conservación, Real Jardín Botánico (RJB-CSIC), Madrid, Spain.
Publications dans "Boraginaceae" :
1 publication dans cette catégorie
Affiliations :
Departamento de Biodiversidad y Conservación, Real Jardín Botánico (RJB-CSIC), Madrid, Spain.
Centro de Investigación en Biodiversidad y Cambio Global (CIBC-UAM), Universidad Autónoma de Madrid, Madrid, Spain.
Departamento de Biología (Botánica), Universidad Autónoma de Madrid, Madrid, Spain.
Publications dans "Boraginaceae" :
1 publication dans cette catégorie
Affiliations :
Centro de Investigación en Biodiversidad y Cambio Global (CIBC-UAM), Universidad Autónoma de Madrid, Madrid, Spain.
Departamento de Biología (Botánica), Universidad Autónoma de Madrid, Madrid, Spain.
Publications dans "Boraginaceae" :
1 publication dans cette catégorie
Affiliations :
Centro de Investigación en Biodiversidad y Cambio Global (CIBC-UAM), Universidad Autónoma de Madrid, Madrid, Spain.
Departamento de Biología (Botánica), Universidad Autónoma de Madrid, Madrid, Spain.
Publications dans "Boraginaceae" :
1 publication dans cette catégorie
Affiliations :
Departamento de Biodiversidad y Conservación, Real Jardín Botánico (RJB-CSIC), Madrid, Spain.
Publications dans "Boraginaceae" :
Acquired hemophilia A (AHA) is a rare, life-threatening hemorrhagic disease caused by autoantibodies against factor VIII (FVIII), and bypassing agents (BPA) are used to control bleeding. However, some...
Haemophilia B patients with factor IX inhibitors have particularly unmet needs for conventional therapy....
Phase II/III clinical trial, multicentre, open-label, prospective, self-controlled study was conducted to assess MC710 prophylaxis in haemophilia B patients with inhibitors....
We enrolled haemophilia patients who had received episodic or prophylactic treatment with bypassing agents up to that time. The participants continued their conventional therapy for 24 weeks and then ...
A total of 11 male haemophilia B patients were enrolled. The median ABR ratio for each participant (the prophylaxis period ABR divided by the conventional therapy period ABR) was .33 (2.1/6.5), range ...
MC710 prophylaxis is considered to be decrease the bleeding rate in haemophilia B patients with inhibitors without safety concerns....
Coronary artery disease (CAD) is associated with a prothrombotic tendency including increased factor (F) VIIa-antithrombin (FVIIa-AT) complexes, a measure of tissue factor (TF) exposure, and activated...
In 120 CAD patients, we assessed FVIIa-AT complex concentrations and the presence of circulating FXIa and active TF. Levels of 8-iso-prostaglandin F2α (8-iso-PGF2α), interleukin-6, high-sensitivity C ...
FVIIa-AT complexes were positively associated with current smoking and multivessel CAD. Elevated FVIIa-AT complexes characterized patients with circulating FXIa and/or active TF in association with in...
This study is the first to show that high FVIIa-AT complexes characterize advanced CAD patients with detectable FXIa and active TF, which is, in part, driven by oxidative stress. High FVIIa-AT complex...
Hematoma expansion shift (HES) analysis can be used to assess the biological effect of a hemostatic therapy for intracerebral hemorrhage. In this study, we applied HES analysis to individual patient d...
We generated polychotomous strata of HES using absolute growth thresholds (≤0/<6/≥6 mL) and quintiles of percent volume change. The relationship between treatment and HES was assessed using proportion...
The primary analysis included 721 patients. At 24 hours, 36% (134/369) of rFVIIa-treated patients exhibited no hematoma expansion as compared with 25% of placebo (88/352)-treated patients. Significant...
The association between rFVIIa and hematoma growth arrest is most pronounced in patients with larger baseline volumes but is evident across the full spectrum of treated patients....
Diffuse pulmonary haemorrhage is an ominous condition that has a high paediatric mortality rate. Recombinant activated factor VIIa (rFVIIa) is a powerful haemostatic agent which has been used intraven...
Tissue factor (TF), a transmembrane glycoprotein, plays a profound role in the formation of the tissue factor-factor VIIa (TF-FVIIa) complex that initiates factor Xa (FXa) generation followed by throm...
The present study aimed to understand how cholesterol affects structural modulations on the tissue factor-factor VIIa-factor Xa ternary complex (TF-FVIIa-FXa). Additionally, we aimed to illustrate the...
We set up the following 4 systems in different lipid environments: TF-FVIIa-FXa in POPC:POPS (CS), TF-FVIIa-FXa in POPC:POPS:CHOL (CSL), Palmitoylated TF-FVIIa-FXa in POPC:POPS:CHOL (CSLP), and Palmit...
Hydrogen-bond and contact probability analysis were performed between various important domains of TF-FVIIa-FXa and notable novel interactions: Asn93...
Analysis of molecular dynamic simulation data suggests that the presence of cholesterol and palmitoylation may contribute to structural rigidity, stability, and compactness of key domains of TF-FVIIa-...
The clotting or hemostasis system is a meticulously regulated set of enzymatic reactions that occur in the blood and culminate in formation of a fibrin clot. The precisely calibrated signaling system ...
The 52-year-old patient, with European, Cherokee and African American origins, FS was identified as having low FVII (10%) prior to elective surgery for an umbilical hernia. He was given low doses of N...
FS has a congenitally mutated FVII/FVIIa gene, which carries a R315W missense mutation in one allele and a mutated start codon (ATG to ACG) in the other allele, thus rendering the patient effectively ...
Factor VII can be considered the gatekeeper of the coagulation system. Here we describe an inherited mutation in which the gatekeeper function is altered. Instead of the expected bleeding manifestatio...
In the last couple of decades, numerous investigations have shed considerable light on how precisely factor VIIa (FVIIa) mediates the initiation of blood coagulation upon association with its cofactor...
Tissue factor (TF), an initiator of extrinsic coagulation pathway, is positively correlated with venous thromboembolism (VTE) of tumor patients. Beyond thrombosis, TF plays a vital role in tumor progr...
Tissue factor (TF), the primary initiator of the extrinsic coagulation pathway, contributes to the generation of a hypercoagulable and prothrombotic state in cancer patients. TF pathway inhibitor (TFP...
A literature search was performed from inception to April 30, 2022 in the PubMed and Google Scholar databases....
TFPI1 and TFPI2 are homologs with different protease inhibitory activities in the coagulation and fibrinolysis system. TFPI1 inhibits TF/factor VIIa (FVIIa) catalyzed factor X (FX) activation. On the ...
TFPI1 and TFPI2 may have different key functions in regulating the coagulation and fibrinolytic systems....